Small Molecules

31 May 2007 Celsion Completes Enrollment in Phase I Liver Cancer Study
31 May 2007 Antares and the Population Council Initiate Phase I Clinical Study with Innovative Low-Dose Contraceptive
31 May 2007 FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
31 May 2007 Data Published in the New England Journal of Medicine Showed TORISEL Extended Median Overall Survival for Patients with Advanced Renal Cell Carcinoma
31 May 2007 Theravance Announces Acceptance of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
31 May 2007 CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds
30 May 2007 The imminent change of the antithrombotics market
30 May 2007 FoldRx Announces Its Phase II/III Clinical Study with Lead Clinical Candidate
30 May 2007 Positive Final Data from HyCAMPTM Phase II Trial in Metastatic Colorectal Cancer
30 May 2007 Sosei Announces Start of SD118 Phase I Studies
30 May 2007 Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat
30 May 2007 Entremed commences phase 2 clinical trial combining Panzem(R) NCD and temodarin brain cancer patients
30 May 2007 FDA approves XYZAL(R) tablets for the treatment of seasonal and year round allergies, and chronic urticaria
30 May 2007 Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
29 May 2007 Glenmark's lead candidate for pain, GRC 6211, to enter Phase II
26 May 2007 Pipex Pharmaceuticals Announces Presentation of Phase I/II Clinical Trial Results of COPREXA (Oral Tetrathiomolybdate) for the Treatment of Refractory Idiopathic Pulmonary Fibrosis (IPF)
25 May 2007 SCHWARZ PHARMA Submits Marketing
25 May 2007 Salvacyl(R)/Mmoapar(R) 3-month formulation obtained european mutual recognition for treatment of sexual deviations
25 May 2007 Exelixis Files IND Application for XL019, a Novel Anticancer Compound Targeting the JAK/STAT Signaling Pathway
25 May 2007 NeuroSearch's license partner Abbott initiates clinical Phase I study with ABT-107
25 May 2007 Approval of an Additional Indication of Combination Therapy of Glufast(R) and
25 May 2007 In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, In Reducing Painful Symptoms in SSRI Non- or Partial-responders with Depression
25 May 2007 FDA Approves Tindamax(R) for Bacterial Vaginosis
25 May 2007 ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN(R) in Crohn's Disease at the Digestive Disease Week 2007 Conference
25 May 2007 Theravance Announces Results From Preclinical Research and Phase 1 Clinical Studies With Investigational Gastrointestinal Motility Compound Presented at 2007 Digestive Disease Week

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top